Biotech Promises Future Chances
Biotech Promises Future Chances
Biotechnology is a new field of research with many involved subjects and applications. Some its subjects can be named as Molecular genetics, Biochemistry, Mircobiology, Immunology, Genetic engineering and some of Health and Medicine, Agriculture and Animal Husbandary. Its research results serve the developing of medicine, vaccines and diagnostics, productivity, energy production and conservation, quality of seeds, insecticides and fertilizers, pollution control and waste management. All these advantages make this fields become the most promising one for your carreer.
The scope of biotechnology has grown up very fast as that of information technology or human resource development sector, the employment has shown great scope and future in this field they can find careers with pharmaceutical companies, chemical, agriculture and allied industries like of research centers.
They can be employed in the areas of planning, production and management of bio-processing industries. All the developed and developing country is putting a lot of investment on the research laboratories and the development of entrepreneurship development. Job in the biotech companies or related to life sciences with wide range from equipment, chemicals, pharmaceuticals, diagnostics and development of vaccines or antibiotics. If a candidate with sufficient knowledge and degree of molecular biology and applied science in plant, animal or microbial biotechnology laboratories or in horticulture, food science can easily get a job with no time.
Career options has been remarkably opened increasing popularity and explosive growth, there is plenty of opportunities available in Biotechnology field i.e., research Scientist, teacher, science writer, Bioinformists, Quality Control Officer, analyst or Production in-charge in the Food, Chemical and Pharmaceutical industry.
As soon as the Human Genome Project (HGP) has been finished every country is investing more on the biotech field as it has lot potential to stabilize the economy of a country and with time it has given the answer to many hereditary diseases also. So, the field is still wide open the best part of opportunities has not came it has to come in the future.
shiju mathew
Question by anonymous89: Jobs for masters in plant biology or plant biotechnology graduates?
Hey all
What do u know about career options for graduates with a masters degree in plant biology or plant biotech ? Do u know anything about how much they earn ?
Best answer:
Answer by Walama
In industry, more than $ 50K. In academia, $ 35K at most, and you spend most of your day begging for funding. Unless you’re best friends with or related to someone who works for a drug company deriving plant-based pharmaceuticals, it’s a very risky career path.
Add your own answer in the comments!
Incoming search terms:
Categories: Plant Biotech Jobs Tags: Biotech, Chances, Future, Promises
What Are The Future Prospects of Biotechnology?
What Are The Future Prospects of Biotechnology?
Biotechnology is a bundle of techniques that are applied to living cells. The work of biotech engineer is to produce these living cells into a particular product of improved quality. This technology is the exploitation of natural resources at the microbial and molecular level for the benefit of mankind. It normally deals with the management of living organisms for improving the products, enhance plants and animals or generate microorganisms for making human life much better.
In today’s world, biotechnology is related to the genetic information of living organisms that are called DNA (deoxyribonucleic acid). This high technology supports the transformation of so-called codes of nature. Students, who have keen interest in Biotechnology and want to make their bright future in this field, have a lot of career opportunities in this field. Students can do specialization in any of the six main fields of biotechnology.
1) Biomedical Engineer: – A biomedical engineer is an expert to form artificial body parts that are called prostheses. Students, who have specialization in this field, can make their career as physical therapists, computer hardware engineer, mechanical engineer and surgeons too.
2) Clinical Laboratory Technologists: – Students can also do specialization for checking the symptoms of any disease as well as to detect body fluids and tissues. In this field, one can work as a pathologist, chemist, biological or a material scientist.
3) Forensic Scientists: – A forensic scientist or crime laboratory analyst provides significant scientific information that can be crucial for the criminal proceedings. The career options of this field are detectives, archaeologists and anthropologists.
4) Pharmacists: – The work of pharmacists is to distribute medicines as well as guiding patients for correct medication and appropriate dosage. In this field, there are unlimited career options that include advanced practice nurses, anesthesiologists, psychiatrists and pharmacy technicians.
5) Medical Scientists: - A medical scientist conducts intensive research on bacteria and different viruses that are the root cause of various diseases and they utilize their research for creating a variety of medicines and vaccines to treat these diseases.
6) Biological Scientists: – This field includes the study of animals, plants and microscopic organisms. Students can work in various fields such as food and agricultural scientists, pharmacists, veterinarians, biomedical engineers, conservation, general practitioners.
In short, Biotechnology is one of the most prominent branches of future. This is an interdisciplinary science that relies on biology and other subjects as mathematics, physics, chemistry and engineering. After completing this course, one can easily get a good job in this field.
This article is all about the importance of Biotechnology. Everybody wants to make his bright career in the most emerging field. In this article, we are also talking about Sharda Group of Institutions that offers Biotechnology program. If you want to know more about this Institute, you can visit: http://www.sgei.org/
The Future of Biotechnology Starts at Montgomery College. Montgomery College (MD) can help you get the education and training you need for one of the nation’s fastest-growing industries. Apply today! For more information please visit www.montgomerycollege.edu/biotech or call 240-567-5000 Montgomery College…Endless Possibilities
Video Rating: 5 / 5
Question by april: What does it take to study biotechnology?
What classes do i need to take in highschool for a possible career in biotechnology?
Best answer:
Answer by Aquaboy
1. Math Classes (especially Calculus, if available)
2. Biology (obviously!)
3. Chemistry (there is a lot of chemistry in biology)
4. Physics (useful for later on in your biotechnological studies, when you’ll encounter topics such as, pharmacokinetics)
Add your own answer in the comments!
Incoming search terms:
- Future prospects of biotechnology
- biotechnology future prospects
- future prospect of biotechnology
- future prospects in biotechnology
- future prospective of biotechnology
- future propect of biotech
- what are the furture pro spect of biotechnology
- the future prospects of biotechnology
- the future prospect of biotechnology
- PROSPECTS OF BIOTECHNOLOGY
- future prospectus of biotechnology
- feature prospect of biotechnology
- future prospects of biotech
- furture prospects of biotechnology
- futuer prospectus of biotechnology
Categories: Career In Biotechnology Tags: applied biology and biotechnology prospect, benefit, Biology, Biomedical, biomedical engineer, Biotechnology, biotechnology biotechnology, body, body fluids, bundle, cause, computer hardware engineer, correct medication, course, crime laboratory, criminal proceedings, deoxyribonucleic acid, everybody, exploitation of natural resources, fields of biotechnology, forensic scientist, forensic scientists, Future, future prospects, future prospects of biotechnology, genetic information, Group, interest, Laboratory, laboratory analyst, laboratory technologists, level, living organisms, mankind, material scientist, mechanical engineer, Medical, nature, Pharmacists, Pharmacy, plants and animals, prospects, root, Science, scientist, Sharda, Study, Technologists, Technology, work
Updates from PROT, MNTA, and LIFE
Updates from PROT, MNTA, and LIFE
crwefinancelogo2
signup3m
Proteonomix Inc (OTC BB: PROT) a company, which focuses on stem cell therapies for diabetes and cardiac injury, is planning to lead the research community into the future with the introduction of a new platform for growing contaminant-free human stem cells, which will serve as a catalyst for bringing feasible treatments to market. Working with top scientists and institutions around the world, Proteonomix is also working on dramatically increasing the donor-recipient match rate by establishing a cord blood bank that uses proprietary technology. Umbilical cord blood stem cells are already recognized as a viable therapy for more than 80 diseases, a number that continues to grow.
PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, recently reported it’s financial results for the quarter ended June 30, 2010. For the second quarter of 2010, the Company reported a net loss of .0 million, compared with a net loss of .8 million for the same period last year. At June 30, 2010, the Company had cash, cash equivalents, and marketable securities of .7 million, compared with .7 million at December 31, 2009.
Revenue for the second quarter of 2010 was .8 million, compared to .6 million for the same period last year. The decrease in revenue was due to a decrease in reimbursable manufacturing expenses associated with our M356 program and a decrease in reimbursable expenses associated with our enoxaparin sodium injection program as the ANDA review process approached completion.
Research and development expenses for the second quarter of 2010 were .8 million, compared to .7 million for the same period last year. The decrease in research and development expenses principally resulted from a decrease in manufacturing, process development and third-party research costs in support of our M356 program and clinical development costs due to the completion of our M118 Phase 2a clinical trial in June 2009.
MNTA is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.
Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. LIFE systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of .3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference.
LIFE reported their results for its second quarter ending June 30, 2010. Their Non-GAAP revenue for the second quarter was 6 million, an increase of 8 percent over the 9 million reported for the second quarter of 2009. Excluding the impact of currency and prior acquisitions and divestitures, organic revenue for the quarter grew 6 percent over the same period in the previous year.
http://crwefinance.com/img/crwefinance_new_buscard2.jpg
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)
Categories: 2010 Discoveris Of Biotechnology Tags: aging skin care, aging skin care products, anti aging skin care, bank, biotechnology company, cardiac injury, Care, Cell, cellular therapy, com, completion, cord blood bank, cord blood stem cells, crwefinancelogo, From, Future, human cells, June, Life, life updates, manufacturing, medicine institute, MNTA, momenta pharmaceuticals inc, nasdaq:mnta, number, OTC, otc bb, percent, platform, promising research, PROT, regenerative, skin, skin care products, Sperm, stem cell biology, Stock, Technology, therapeutic modalities, tissue bank, Translational, translational medicine, treatment, Updates, working, year, York
